Our News

Congratulations on Mariaelena Nabors’ acceptance into the UNC CCBTP (Cancer Cell Biology Training Program) T32! Mariaelena is currently a graduate student in Yeh Lab.     Mariaelena Nabors

Dr. Deborah Weighill, current post-doctoral trainee in Yeh lab, will be funded by the for Pope Fellowship Award for a period of 2 years, effective July 1, 2021.  Congratulations!  

Congratulations to Sandra (Sandy) Zarmer on receiving the NIH F31 Pre-Doctoral Fellowship!  Sandy is a Graduate Research Assistant of the Department of Pharmacology. 

The Committee on Faculty Research and Scholarly Leaves has approved Dr. Laura (Xianlu) Peng, Assistant Professor in the Pharmacology Department, for a Junior Faculty Development Award. The award amount is $10,000. Congratulations!  

The American Association for Cancer Research presented the founding members and the current project team associated with The Cancer Genome Atlas with the 2020 AACR Team Science Awards during the AACR Virtual Annual Meeting II on June 24.

University of North Carolina Lineberger Comprehensive Cancer Center researchers reported the discovery of a potential treatment strategy to reduce resistance to a chemotherapy combination used to treat pancreatic cancer, one of the deadliest cancer types.

A study from the University of North Carolina Lineberger Comprehensive Cancer Center could help predict resistance to treatments for pancreatic cancer, one of the deadliest cancer types. In the journal Clinical Cancer Research, a journal of the American Association for Cancer Research, researchers led by UNC Lineberger’s Jen Jen Yeh, MD,...

In the journal Nature Communications, researchers from the University of North Carolina Lineberger Comprehensive Cancer Center reported they have designed a computational method for separating the different tissues in a particular sample – whether that is stroma in the case of pancreatic cancer, immune cells or cancer cells.

The University of North Carolina at Chapel Hill Integrated Translational Oncology Program (UNC-iTOP) is a T32 training program focused on training clinicians (MDs), basic scientists (PhDs), and PhD, MD and MD-PhD candidates in clinical/translational disease-based research at the interface of clinical oncology and cancer biology using patient samples.

We are thrilled to congratulate Matthew Lipner of Yeh lab on successfully completing his PhD defense, an achievement that follows years of hard work. A successful PhD defense is one of the landmark achievements of a researcher’s career and is sure to be only the first step in Matt’s journey.